Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain
NCT03936387Phase 3Completed
- Sponsor
- Boston Children's Hospital
- Start
- Jul 2019
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Boston Children's Hospital. Primary endpoint: Number of Participants Who Completed a Successful Intervention With No Major Adverse Events at 48 hours. Started Jul 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03936387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03936387.